繁體版 / 簡體版
 
ABOUT US
/ OVERVIEW

OVERVIEW

    MICROBIO, which was founded in 2000, has experienced over a decade of growth and remains dedicated to “novel therapeutics development and human lifestyle improvement”. MICROBIO Group’s approach to innovative and responsible drug development has led to two successful drug approvals by the Taiwanese Food and Drug Administration (TFDA). In addition to drug development, we have expanded into other markets such as top-line medical devices, functional health foods, organic agricultural products, and biotechnology venture capital. We always welcome strategic collaborations with leading research institutions, international pharmaceutical companies, and novel biotechnology platforms, all of which allow us to bridge gaps in medical treatments. It is our mission to fulfill unmet healthcare needs, and transform scientific breakthroughs into clinical research in the hopes of providing new treatment options for patients. Our core values, modesty and innovation, drive us to take initiative, stay competitive, and position us as an influential leader in the global market.


陕西快乐十分中奖技巧 七乐彩111 e球彩 重庆幸运农场高手预测 陕西快乐十分昨天开奖 多多游戏通比牛牛辅助 江苏11选5历史开奖数据 陕西快乐十分走势图今天 江苏时时彩视频直播 2021平特一肖算法 新世界棋牌登陆 e球彩进球数固定奖金是多少 山东群英会最新玩法 意大利对德国比分预测 微乐捉鸡麻将下载 最新mg欧美厅 亿客隆平台登录